Table 3 Outcomes assessing potential effectiveness
Outcomes | Pediatric tubes (n = 100) | Adult tubes (n = 100) | Absolute difference (95% CI) | Hazard or risk ratio(95% CI) |
|---|---|---|---|---|
RBC transfusion or hemoglobin <7 g/dL, n (%) | 6 (6) | 11 (11) | − 5 (− 14 to 4) | 0.69 (0.25 to 1.9) |
By baseline hemoglobin | ||||
7 to 9.49 g/dL | 5 (18.5) | 11 (38) | − 19 (− 42 to 3.5) | 0.57 (0.2 to 1.67) |
9.5 to 11.99 g/dL | 1 (3) | 0 | 3 (− 3 to 9) | NA |
≥ 12 g/dL | 0 | 0 | NA | NA |
Rate of change in hemoglobin, g/dL/day | − 0.19 | − 0.14 | − 0.05 (− 0.15 to 0.06) | NA |
By baseline hemoglobin | ||||
7 to 9.49 g/dL | − 0.07 | − 0.18 | 0.11 (− 0.1 to 0.3) | NA |
9.5 to 11.99 g/dL | − 0.18 | − 0.05 | − 0.13 (− 0.3 to 0.01) | NA |
≥ 12 g/dL | − 0.29 | − 0.24 | − 0.05 (− 0.3 to 0.2) | NA |
Mortality in the ICU, n (%) | 9 (9) | 10 (10) | − 1 (− 10 to 8) | 0.9 (0.4 to 2.1) |
Days in the ICU, median (IQR) | 2.5 (1.5–4) | 2.5 (1.5–5) | 0 | 0.9 (0.7 to 1.2) |